Blog
RSS FeedPosted by Michael Wonder on 01 Jun 2020
New combination therapy now reimbursed for Australians living with incurable blood cancer
1 June 2020 - New combination therapy now reimbursed for Australians living with incurable blood cancer. ...
Posted by Michael Wonder on 01 Jun 2020
Pharmacist claiming of paracetamol 500 mg with codeine 30 mg tablet prescriptions from 1 June 2020
1 June 2020 - Commencing 1 June 2020, the Pharmaceutical Benefits Scheme listings for opioid medicines will change. Included in ...
Posted by Michael Wonder on 31 May 2020
Schedule of Pharmaceutical Benefits - 1 June 2020
1 June 2020 - The June 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 May 2020
Greater flexibility for Australians with severe asthma with reimbursement of at-home
1 June 2020 - Greater flexibility for Australians with severe asthma with reimbursement of at-home, self-administration delivery of Nucala (mepolizumab) ...
Posted by Michael Wonder on 28 May 2020
Painkiller packs cut down to size as opioid crackdown intensifies
27 May 2020 - The drugs have become household names in Australia: oxycodone, codeine, morphine and tramadol. ...
Posted by Michael Wonder on 25 May 2020
Final report for the post-market review of pulmonary arterial hypertension medicines
25 May 2020 - The final report and outcomes of the post-market review of pulmonary arterial hypertension medicines are now publicly ...
Posted by Michael Wonder on 20 May 2020
Public Consultation - Draft 2020-21 Cost Recovery Implementation Statement for listing medicines on the PBS and designated vaccines on the NIP
20 May 2020 - As outlined in the April 2020 PBS news item – ‘Cost Recovery – Consultation Feedback’, the current ...
Posted by Michael Wonder on 14 May 2020
Serious shortages substitution notice
14 May 2020 - Where a serious shortages substitution notice has been issued by the Therapeutic Goods Administration and supported ...
Posted by Michael Wonder on 14 May 2020
Consumer comments needed for proposed new listings on the PBS
12 May 2020 - Lung Foundation Australia is seeking input from consumers to inform submissions on proposed listings of respiratory ...
Posted by Michael Wonder on 11 May 2020
COVID-19: pharmacists and GPs brawl over powers to dispense medicines
11 May 2020 - Chemists are using the coronavirus health crisis to push for a permanent increase in their power ...
Posted by Michael Wonder on 04 May 2020
Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy
1 May 2020 - The reimbursement of the immune checkpoint inhibitors is challenging. ...
Posted by Michael Wonder on 04 May 2020
New listings welcomed amongst COVID backdrop
4 May 2020 - Medicines Australia welcomes Friday’s announcement by Minister for Health the Hon Greg Hunt on the PBS ...
Posted by Michael Wonder on 03 May 2020
Agenda for the July 2020 PBAC meeting (revised)
1 May 2020 - Published on Wednesday and revised (with no notification) by Friday. ...
Posted by Michael Wonder on 01 May 2020
Breakthrough new medicine listings on the PBS for cardiovascular disease, rheumatoid arthritis and asthma
1 May 2020 - There is new hope for thousands of Australians with cardiovascular disease, rheumatoid arthritis and asthma with new ...
Posted by Michael Wonder on 30 Apr 2020
Schedule of Pharmaceutical Benefits - 1 May 2020 update
1 May 2020 - The May 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...